Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析

◆英語タイトル:Tianda Pharmaceuticals Ltd (455) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH470679FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic areas such as cardio-cerebrovascular drugs, pediatric drugs, anti-flu and respiratory drugs, anti-infective drugs, anti-diabetic drugs, anti-neoplastics drugs and detoxification drugs. Its cardio-cerebrovascular drugs comprise zhikang granules, cerebroprotein hydrolysate injection, valsartan capsules, aceglutamide injection, vinpocetine injection and aspirin enteric-coated tablets. Tianda Pharma also conducts research and development for vaccines and blood products. The company operates two research and development centers and production bases in Zhuhai and Kunming, China. The company has operations in China and Australia. Tianda Pharma is headquartered in Hong Kong.

Tianda Pharmaceuticals Ltd Key Recent Developments

Mar 16,2021: The third TDMall in the world opened in Sydney, Australia
Nov 27,2020: Tianda Pharmaceuticals : Interim results announcement for the six months ended 30 September2020

This comprehensive SWOT profile of Tianda Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tianda Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tianda Pharmaceuticals Ltd – Key Information
Tianda Pharmaceuticals Ltd – Overview
Tianda Pharmaceuticals Ltd – Key Employees
Tianda Pharmaceuticals Ltd – Key Employee Biographies
Tianda Pharmaceuticals Ltd – Key Operational Heads
Tianda Pharmaceuticals Ltd – Major Products and Services
Tianda Pharmaceuticals Ltd – History
Tianda Pharmaceuticals Ltd – Company Statement
Tianda Pharmaceuticals Ltd – Locations And Subsidiaries
Tianda Pharmaceuticals Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tianda Pharmaceuticals Ltd – Business Description
Tianda Pharmaceuticals Ltd – Corporate Strategy
Tianda Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Tianda Pharmaceuticals Ltd – Strengths
Tianda Pharmaceuticals Ltd – Weaknesses
Tianda Pharmaceuticals Ltd – Opportunities
Tianda Pharmaceuticals Ltd – Threats
Tianda Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Tianda Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tianda Pharmaceuticals Ltd, Key Information
Tianda Pharmaceuticals Ltd, Key Ratios
Tianda Pharmaceuticals Ltd, Share Data
Tianda Pharmaceuticals Ltd, Major Products and Services
Tianda Pharmaceuticals Ltd, History
Tianda Pharmaceuticals Ltd, Key Employees
Tianda Pharmaceuticals Ltd, Key Employee Biographies
Tianda Pharmaceuticals Ltd, Key Operational Heads
Tianda Pharmaceuticals Ltd, Other Locations
Tianda Pharmaceuticals Ltd, Subsidiaries
Tianda Pharmaceuticals Ltd, Key Competitors
Tianda Pharmaceuticals Ltd, SWOT Analysis
Tianda Pharmaceuticals Ltd, Ratios based on current share price
Tianda Pharmaceuticals Ltd, Annual Ratios
Tianda Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Isofol Medical AB (ISOFOL):製薬・医療:M&Aディール及び事業提携情報
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company that develops folate-based therapies for the treatment of cancer patients. The company offers clinical lead candidate Modufolin, a novel folate-based therapy, which is developed to increase the efficacy and reduce the side …
  • Agile Therapeutics Inc (AGRX):企業の財務・戦略的SWOT分析
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • First Mutual Holdings Limited:企業の戦略・SWOT・財務情報
    First Mutual Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary First Mutual Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BioChain Institute Inc-医療機器分野:企業M&A・提携分析
    Summary BioChain Institute Inc (BioChain) is a medical device company that designs, develops and markets diagnostic products. The company provides processed bio-sample products and analysis services used in translational medicine, companion diagnostics, and clinical product research and development. …
  • Banca IFIS SpA:企業の戦略・SWOT・財務情報
    Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report Summary Banca IFIS SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Jazz Pharmaceuticals Plc (JAZZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Jazz Pharmaceuticals plc (Jazz Pharmaceuticals) is a specialty biopharmaceutical company which identifies, develops and commercializes medicines with focus on narcolepsy, cancer, pain and psychiatry. Its major marketed products include Xyrem, sodium oxybate oral solution, for the treatment o …
  • iX Biopharma Ltd (42C):企業の財務・戦略的SWOT分析
    Summary iX Biopharma Ltd (iX Biopharma) is a pharmaceutical company that provides that offers drug delivery and formulation. The company's pipeline product portfolio includes development of drugs for various indications such as opioid-sparing for acute, severe and chronic pain; male erectile dysfunc …
  • PT Tempo Scan Pacific Tbk (TSPC):企業の財務・戦略的SWOT分析
    PT Tempo Scan Pacific Tbk (TSPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Electromed Inc (ELMD):企業の財務・戦略的SWOT分析
    Summary Electromed Inc (Electromed) is a medical device company that designs, manufactures and markets respiratory care products using airway clearance technologies. The company provides smartvest airway clearance system used through in-home and in-patient therapies for respiratory treatments. It of …
  • Getinge AB (GETI B):企業の財務・戦略的SWOT分析
    Getinge AB (GETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Odakyu Electric Railway Co., Ltd. (9007):企業の財務・戦略的SWOT分析
    Odakyu Electric Railway Co., Ltd. (9007) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Napp Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Program for Appropriate Technology in Health-製薬・医療分野:企業M&A・提携分析
    Summary Program for Appropriate Technology in Health (PATH) is a healthcare organization that offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. The organization offers HIV and AIDS, influenza, malaria and tuberculosis care services. It develo …
  • Shanghai RAAS Blood Products Co Ltd (002252):企業の財務・戦略的SWOT分析
    Shanghai RAAS Blood Products Co Ltd (002252) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Bank of Hawaii Corp (BOH):企業の財務・戦略的SWOT分析
    Bank of Hawaii Corp (BOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Novotech (Australia) Pty Ltd (Novotech) is a contract research organization that offers clinical development services. The organization’s services include clinical trials, data management, biostatistics analysis, audits, regulatory affairs, medical writing, site management and commercializat …
  • Bayer AG (BAYN):企業の財務・戦略的SWOT分析
    Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Hydro One Networks Inc:電力:M&Aディール及び事業提携情報
    Summary Hydro One Networks Inc (Hydro One), a subsidiary of Hydro One Ltd, is an electric utility service provider. The company offers residential services, business services, rates and billing, saving money and energy, power outages and safety services. It provides move in move out, submit a meter …
  • The Saudi British Bank (1060):企業の財務・戦略的SWOT分析
    The Saudi British Bank (1060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Genomic Expression Inc:企業の製品パイプライン分析
    Summary Genomic Expression Inc (Genomic Expression) is a provider of cancer diagnostics services that offers treatments for cancer diagnostics for personalized medicine. The company offers products such as sample sequencing sample preparation kit and analytical platform. Its sequencing platform prov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆